News / Events
Home/News/Events/News / Events/Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA

Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA

UPDATE : 2019/09/03
Virginia Contract Research Organization Co., Ltd.(VCRO) has successfully conducted and managed the clinical operation, data management, statistical analysis, medical writing, and GCP inspection of a phase I cell therapy IND-used study. In this clinical trial, VCRO has conquered diverse challenges the fast-paced nature of an cell therapy study, and overcame all the difficulties. On Sep-2019, the study was granted with an approval by TFDA for the GCP inspection. Just another epic VCRO milestone that we are excited to share with you!
新网络赚钱方法
张天师四肖中特 2019白菜娱乐平台论坛 11选5怎么赚钱 河南体彩481规则 水浒传一元一分现金版 迷你罗 八大胜娱乐 彩票开奖查询88期2019 山东十一选五遗漏 2019山东时时彩诈骗案 急速赛车90秒 河北快三过滤软件 极速赛车人工计划精准软件 会员料三肖中特公开 双色球蓝球走势新图表